Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Menu
March 16-18, 2027 |San Diego Convention Center, San Diego, CA, USA

The Best of the West: Defining the Future of Bioprocessing

From Cell Line Development to Commercial Manufacturing: The Gateway to Integrated Bioprocessing Systems, Technical Breakthroughs & Expert Networking

Download BPI US West 2026 Brochure + Google Keynote PresentationSpeak at BPI US West 2027: Submissions Due Sept 18

Call for Speakers for BioProcess International US West 2027

Highlight your company's work at BPI US West 2027 by submitting a speaking proposal today. But hurry, speaking slots are limited and the deadline for speaker submissions is September 18. The full 2027 agenda and early attendee registration rates will be published in early October.

Submit a Speaking Proposal Now

The Must-Attend Event in 2027 for Bioprocessing Innovators

Cell Line Development and Engineering

  • Convert fragmented CLD data into reusable process intelligence with standardized metadata and analytics to compress cycles, reduce experiments, and speed confident clone decisions.
  • Engineer hosts and vectors for complex modalities to lift productivity, mitigate product-quality liabilities, and link early behavior to CQAs and manufacturability to prevent late rework.
  • Build faster, lower-risk CLD organizations with automation, high-throughput screening, and cross-functional governance that accelerate timelines without compromising scale-up success.

Cell Culture and Upstream Processing

  • Build robustness that transfers by optimizing media, feeds, and metabolism and by validating scale-down models to improve reproducibility and scale-up readiness beyond titer alone.
  • Bring product-quality insight in line with PAT, at-line analytics, soft sensors, and feedback control to shorten learning loops and stabilize CQAs in real time.
  • Cut experiments and touch time using AI-assisted DOE, high-throughput platforms, and automation to accelerate decisions, reduce FTE burden, and enable confident intensification.

Downstream Processing

  • Unblock the harvest bottleneck and evolve capture/polish platforms for complex molecules to maintain yields and impurity control as upstream intensifies.
  • Use mechanistic models, digital twins, and structured data to make validation-ready decisions tied to specific CQAs, accelerating development and de-risking lifecycle changes.
  • Design for end use with high-concentration processing and a strong DS–DP interface, applying phase-appropriate strategies and targeted automation to speed to clinic without costly redesigns.

Accelerating Speed from Early Development to Commercial

  • Reach first-in-human faster by leveraging platforms, parallelization, and early manufacturability screens while embedding transfer-ready packages to avoid late-stage rework.
  • Digitize CMC execution with electronic batch records, integrated data flows, and AI-assisted documentation and knowledge retrieval to remove friction in tech transfer and filings.
  • Treat comparability, validation, and commercial readiness as early design inputs—align specs, robustness, and site fit with evolving ICH guidance under a clear operating model.

Next-Gen Modality, Cell Therapy, and Gene Therapy

  • Industrialize cell therapy with fit-for-scale bioreactors, robust expansion and harvest, and phase-appropriate GMP and raw-material strategies to reduce variability and audit risk.
  • Strengthen viral and nucleic acid production by improving vector yield/purity and full-to-empty control, scaling mRNA/plasmid/LNP manufacturing, and applying ML where it drives consistency.
  • Reduce COGS and scale risk via platform standardization and value-chain design, then select portfolio bets by manufacturability, economics, and regulatory path to raise commercial success odds.

Tailored Bioprocessing Pre-Conference Workshops

  • Workshop 1: Tech Transfer Done Better: Reducing Friction, Risk, and Delay Across Sites and Partners
  • Workshop 2: Process Intensification: What Is Working Now and What Comes Next
  • Workshop 3: AI, Data, and Digital Transformation in Bioprocessing: From Hype to Measurable Value

Transform Your Bioprocessing at BPI US West 2027

Get ready for a game-changing experience that will elevate your team and redefine what's possible in biopharma. At BPI US West 2027, you'll dive into groundbreaking keynotes, immersive hands-on workshops, and dynamic discussions that unite the boldest minds in the industry to tackle biopharma's toughest challenges.

Attendees leave with exclusive insights, powerful connections, and a practical case studies to immediately apply in the the lab. For 2027, expect even more:

  • Cutting-edge content designed to keep you ahead of the curve
  • World-class speakers sharing visionary ideas and actionable strategies
  • Unparalleled networking opportunities to connect with top professionals and thought leaders

Stay ahead of trends, discover the latest technologies, and position your team for success. BPI US West 2027 is the must-attend event for biopharma professionals who want to lead the future of bioprocessing.

Discover the Next Evolution of BioProcess International US West (BPI US West): What’s Going on in 2027

Tech on Display: Explore & Connect

  • Actionable Tech Demos: Witness Live Lab and automation demos to instantly validate new equipment for your workflow.

  • Accelerate Your Pipeline: Connect directly with 90+ suppliers and CDMOs to find next-gen technologies that speed your therapeutic from R&D to commercial scale.

  • Curated Connections: Use the ConnectMe AI Matchmaking App to pre-schedule 1:1 meetings with the qualified decision-makers you need.

The Biopharma Ecosystem in One Place

  • Elite Hub: Meet 800+ global scientists and executives. This is your fastest route to key decision-makers across the entire biopharma pipeline.

  • Targeted Expertise: Instantly access knowledge in Cell & Gene Therapy, Process Development, and Manufacturing Strategy to launch cross-functional projects.

  • Real Relationships: Forge high-trust connections during premium lunches and vibrant outdoor receptions. Business gets personal in the California sunshine.

Meet in the Epicenter of Western Biotech

  • West Coast Biotech Hub: Leverage the event's location in the $1.5 Billion San Diego Life Science Cluster to engage local innovators, investors, and R&D partners.
  • Prime Central Venue: Benefit from the San Diego Convention Center's central downtown location, offering easy access to the airport and all major hotels, minimizing travel time.
  • Recharge and Reset: Take advantage of the year-round sunshine and coastal setting to facilitate relaxed networking, recharge, and maximize your focus over three days.

Find Your Tribe: Who You'll Connect with at BioProcess International US West

+

Global Scientists, Executives, and Technology Leaders Across All Phases of Bioprocessing—From Top Biotech and Pharmaceutical Companies to Emerging Start-ups

+

Exhibitors Devoted to Accelerating Your Product Through the Pipeline to Market

+

Scientific Case Studies and New Data Presentations Across 5 Focused Tracks

William N. Napoli

Scientist, BioProcess Technology and Expression, BioProcess Development

Merck & Co., Inc.

"BPI US West is an ideal meeting to share experiences with industry leaders in the bioprocess field."

Engage Qualified Bioprocessing Decision-Makers!

Whether you're increasing your company profile, launching a new product, or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.

Contact us directly at Partners@informaconnectls.com

View Sponsor ProspectusWhy Sponsor?

FAQs

expand_less

What is BioProcess International US West (BPI West)?

BPI West is a premier bioprocessing conference and exhibition that brings together scientists, innovators, and industry leaders to advance biologics manufacturing. The event focuses on cutting-edge biomanufacturing strategies for monoclonal antibodies, vaccines, cell and gene therapies, and other advanced modalities.

Upcoming BPI Events